Drug Identification System

PillID

← Drug Encyclopedia 🌙

Uses & FDA Indications

Rosuvastatin is a high-intensity statin — among the most potent cholesterol-lowering medications available. It is FDA-approved as an adjunct to diet for adults with primary hyperlipidemia (elevated LDL-cholesterol), mixed dyslipidemia, and hypertriglyceridemia. It is also approved to slow the progression of atherosclerosis in adults as part of a comprehensive treatment strategy.

Rosuvastatin is a key tool for cardiovascular risk reduction. The landmark JUPITER trial demonstrated that rosuvastatin significantly reduced the rate of major cardiovascular events — including heart attack and stroke — even in patients with relatively normal LDL levels who had elevated high-sensitivity CRP (a marker of inflammation). As a result, it is approved for primary prevention of cardiovascular disease in patients without clinical cardiovascular disease but with elevated cardiovascular risk factors.

• Primary hyperlipidemia and mixed dyslipidemia (adjunct to diet)
• Hypertriglyceridemia
• Homozygous and heterozygous familial hypercholesterolemia (including pediatric patients)
• Primary prevention of cardiovascular events in high-risk patients
• Slowing atherosclerosis progression

How It Works

Rosuvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway — the primary route for cholesterol biosynthesis in the liver. By reducing hepatic cholesterol synthesis, rosuvastatin causes compensatory upregulation of LDL receptors on the surface of liver cells. More LDL receptors means more LDL cholesterol is cleared from the bloodstream, resulting in lower circulating LDL levels.

Beyond LDL lowering, statins including rosuvastatin have pleiotropic (additional) cardiovascular benefits: they improve endothelial function, reduce vascular inflammation, stabilize atherosclerotic plaques, and have antithrombotic properties. These effects partially explain why statins reduce cardiovascular events beyond what LDL reduction alone would predict.

Side Effects

Common

• Myalgia (muscle aches and pain) — most common reason for discontinuation
• Headache
• Nausea
• Abdominal pain and constipation
• Asthenia (weakness)
• Mild elevations in liver enzymes (transaminases)
• Proteinuria and hematuria (more common at higher exposures)

Serious

• Myopathy — muscle inflammation ranging from mild pain to severe weakness
• Rhabdomyolysis — rare but life-threatening muscle breakdown releasing myoglobin into the bloodstream, causing acute kidney injury
• Statin-induced immune-mediated necrotizing myopathy (IMNM) — rare autoimmune condition that persists even after stopping the statin
• Severe hepatotoxicity (rare; routine monitoring no longer routinely required by FDA)
• New-onset diabetes mellitus — statins modestly increase diabetes risk
• Cognitive effects — rare reports of memory impairment and confusion (reversible on discontinuation)

Drug Interactions

Drug / Class	Interaction	Clinical Significance
Cyclosporine	Dramatically increases rosuvastatin AUC (up to 7-fold); severe myopathy and rhabdomyolysis risk — contraindicated combination	Contraindicated
Gemfibrozil	Inhibits rosuvastatin hepatic uptake transporters (OATP1B1); increases rosuvastatin levels and myopathy risk significantly	High — avoid combination; use fenofibrate instead if needed
Warfarin	Rosuvastatin may increase INR; bleeding risk increased — close INR monitoring required when starting or changing dose	High — monitor INR closely
Antacids (aluminum/magnesium hydroxide)	Reduce rosuvastatin absorption by ~50% when taken simultaneously	Moderate — take antacid at least 2 hours after rosuvastatin
HIV protease inhibitors (lopinavir/ritonavir, atazanavir)	Increase rosuvastatin plasma concentrations; rhabdomyolysis risk — dose limits apply	High — dose-cap rosuvastatin per labeling
Niacin (high-dose)	Additive risk of myopathy especially at high niacin doses; monitor CPK	Moderate — use lowest effective doses
Ezetimibe	Complementary LDL lowering; no pharmacokinetic interaction; combination may achieve greater LDL reduction	Beneficial — widely used combination

Warnings & Contraindications

• Contraindicated: Pregnancy, active liver disease or unexplained persistent elevations in liver enzymes, breastfeeding, hypersensitivity to rosuvastatin
• Myopathy / rhabdomyolysis risk: Risk is higher with concurrent use of cyclosporine, gemfibrozil, certain antiretrovirals, and niacin; and with hypothyroidism, renal impairment, or advanced age
• Liver function: Obtain liver enzyme tests before starting; if transaminases exceed 3× upper limit of normal persistently, consider discontinuation
• Asian patients: Higher plasma levels observed in patients of Asian ancestry — lower starting exposures are recommended per prescribing information
• Renal impairment: Severe renal impairment increases rosuvastatin exposure; dose adjustment required
• Diabetes risk: Advise patients with pre-diabetes risk factors about the modest increased risk of developing type 2 diabetes

Frequently Asked Questions

Is rosuvastatin stronger than other statins?

Rosuvastatin and atorvastatin are both classified as high-intensity statins, expected to reduce LDL-cholesterol by 50% or more at their respective full strengths. Rosuvastatin is considered among the most potent per milligram of any statin currently available, and at maximum approved doses can achieve some of the greatest absolute LDL reductions. Your prescriber will select the appropriate statin and intensity based on your cardiovascular risk, tolerability, and drug interactions.

Why does rosuvastatin have fewer drug interactions than other statins?

Most statins — including simvastatin, lovastatin, and atorvastatin — are primarily metabolized by CYP3A4 in the liver. Drugs that inhibit CYP3A4 (like many antibiotics, antifungals, and HIV medications) can markedly raise levels of those statins. Rosuvastatin is not metabolized by CYP3A4; it is instead transported by OATP1B1/OATP1B3 and metabolized only minimally. This makes it less susceptible to many common drug-drug interactions, though it is still affected by OATP transporter inhibitors like cyclosporine and gemfibrozil.

Do I need to take rosuvastatin at night?

Unlike some statins (simvastatin, for example), rosuvastatin does not need to be taken at a specific time of day due to its longer half-life of approximately 19 hours. It can be taken at any time, with or without food. Consistency is more important than timing — taking it at the same time each day helps maintain steady-state blood levels and supports adherence.

My muscles have been aching since starting rosuvastatin — should I be worried?

Muscle aches (myalgia) are the most commonly reported side effect of statins. Most cases are mild and not associated with actual muscle damage. However, unexplained significant muscle pain, tenderness, or weakness — especially if accompanied by dark urine — could indicate myopathy or rhabdomyolysis, which require prompt medical attention. Do not stop the medication without speaking to your healthcare provider, as they will assess your symptoms, check creatine phosphokinase (CPK) levels, and help determine the appropriate next step.

→ Statin Side Effects Guide → High Cholesterol Medications Guide